Top compounds associated with response to NPM1


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC 0.31 2e-10
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.21 7e-09
mRNA niclosamide CTRPv2 pan-cancer AAC 0.19 8e-08
mRNA Gemcitabine gCSI pan-cancer AAC 0.27 3e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 4e-07
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.15 1e-05
mRNA thapsigargin GDSC1000 pan-cancer AAC 0.15 2e-05
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 2e-05
Download CSV